Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Kraemer

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 20, 2016
D313Y mutation in the differential diagnosis of white matter lesions: Experiences from a multiple sclerosis outpatient clinicJana Becker, Arndt Rolfs, Nesrin Karabul, et al.
Clinical Neurology and Neurosurgery|May 7, 2010
Activation of working memory in patients at the earliest stage of multiple sclerosis--an fMRI studyHannes Meyn, Markus Kraemer, Armin de Greiff, et al.
Journal of Neurology|June 6, 2019
Histopathology of Moyamoya angiopathy in a European patientMarkus Kraemer, Kathy Keyvani, Peter Berlit, et al.
Neurological Research and Practice|May 15, 2022
Recovery of intracranial stenoses in varicella zoster virus vasculitis after long-term treatment with valacyclovir and prednisoloneMarkus Kraemer, Daniel Strunk, Jana Becker, et al.
Neurological Research and Practice|March 1, 2022
Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a neuroradiological method to help differentiate from primary central nervous system vasculitisDaniel Strunk, Roland Veltkamp, Sven G Meuth, et al.
British Journal of Neurosurgery|June 30, 2012
Differential diagnosis between cerebral ischemia, focal seizures and limb shaking TIAs in moyamoya diseaseMarkus Kraemer, Rolf R Diehl, Frank Diesner, et al.
Neurological Research and Practice|November 22, 2021
Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosisMosche Pompsch, Neslinur Fisenkci, Peter A Horn, et al.
Acta Neurochirurgica. Supplement|June 22, 2011
Genetic and clinical characteristics of Moyamoya disease in EuropeansBoris Krischek, Hidetoshi Kasuya, Nadia Khan, et al.
Journal of Neurology|June 1, 2023
Progression of initially unilateral Moyamoya angiopathy in Caucasian EuropeansDaniel Strunk, Rolf R Diehl, Roland Veltkamp, et al.
Der Nervenarzt|November 4, 2021
[Diagnostics and treatment of giant cell arteritis]Markus Kraemer, Jana Becker, Thorsten Alexander Bley, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 20, 2016
D313Y mutation in the differential diagnosis of white matter lesions: Experiences from a multiple sclerosis outpatient clinicJana Becker, Arndt Rolfs, Nesrin Karabul, et al.
Clinical Neurology and Neurosurgery|May 7, 2010
Activation of working memory in patients at the earliest stage of multiple sclerosis--an fMRI studyHannes Meyn, Markus Kraemer, Armin de Greiff, et al.
Journal of Neurology|June 6, 2019
Histopathology of Moyamoya angiopathy in a European patientMarkus Kraemer, Kathy Keyvani, Peter Berlit, et al.
Neurological Research and Practice|May 15, 2022
Recovery of intracranial stenoses in varicella zoster virus vasculitis after long-term treatment with valacyclovir and prednisoloneMarkus Kraemer, Daniel Strunk, Jana Becker, et al.
Neurological Research and Practice|March 1, 2022
Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a neuroradiological method to help differentiate from primary central nervous system vasculitisDaniel Strunk, Roland Veltkamp, Sven G Meuth, et al.
British Journal of Neurosurgery|June 30, 2012
Differential diagnosis between cerebral ischemia, focal seizures and limb shaking TIAs in moyamoya diseaseMarkus Kraemer, Rolf R Diehl, Frank Diesner, et al.
Neurological Research and Practice|November 22, 2021
Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosisMosche Pompsch, Neslinur Fisenkci, Peter A Horn, et al.
Acta Neurochirurgica. Supplement|June 22, 2011
Genetic and clinical characteristics of Moyamoya disease in EuropeansBoris Krischek, Hidetoshi Kasuya, Nadia Khan, et al.
Journal of Neurology|June 1, 2023
Progression of initially unilateral Moyamoya angiopathy in Caucasian EuropeansDaniel Strunk, Rolf R Diehl, Roland Veltkamp, et al.
Der Nervenarzt|November 4, 2021
[Diagnostics and treatment of giant cell arteritis]Markus Kraemer, Jana Becker, Thorsten Alexander Bley, et al.
Pageof 9